Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,216 JPY | -0.24% | -2.51% | -11.85% |
Mar. 22 | BioArctic Flags Delay in EU Health Regulator's Evaluation of Azlheimer’s Disease Drug | MT |
Mar. 22 | Lifenet to Launch Dementia-Focused Insurance Product in April | MT |
Sales 2024 * | 735B 4.85B | Sales 2025 * | 779B 5.14B | Capitalization | 1,787B 11.8B |
---|---|---|---|---|---|
Net income 2024 * | 41.12B 272M | Net income 2025 * | 50.09B 331M | EV / Sales 2024 * | 2.2 x |
Net cash position 2024 * | 172B 1.14B | Net cash position 2025 * | 184B 1.21B | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
43.7
x | P/E ratio 2025 * |
35.8
x | Employees | 11,076 |
Yield 2024 * |
2.6% | Yield 2025 * |
2.67% | Free-Float | 93.84% |
Latest transcript on Eisai Co., Ltd.
1 day | -0.24% | ||
1 week | -2.51% | ||
Current month | -0.61% | ||
1 month | -0.61% | ||
3 months | -11.85% | ||
6 months | -25.14% | ||
Current year | -11.85% |
Managers | Title | Age | Since |
---|---|---|---|
Haruo Naito
CEO | Chief Executive Officer | 76 | 75-09-30 |
Mitsuru Shomon
DFI | Director of Finance/CFO | - | - |
Makoto Hoketsu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Haruo Naito
CEO | Chief Executive Officer | 76 | 75-09-30 |
Fumihiko Ike
BRD | Director/Board Member | 71 | 21-05-31 |
Toru Moriyama
BRD | Director/Board Member | 69 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.78% | 14 M€ | +10.29% | ||
1.23% | 245 M€ | +19.57% | ||
1.13% | 29,931 M€ | +21.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-29 | 6,216 | -0.24% | 1 237 700 |
24-03-28 | 6,231 | -2.64% | 1,040,200 |
24-03-27 | 6,400 | +0.71% | 1,230,900 |
24-03-26 | 6,355 | +0.92% | 998,900 |
24-03-25 | 6,297 | -1.24% | 1,395,800 |
Delayed Quote Japan Exchange, March 29, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.85% | 11.81B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |